By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Deafness
  • >
  • The 'special' Yorkshire firm using stem cell technology to cure deafness which could save the country billions – Yorkshire Live

The 'special' Yorkshire firm using stem cell technology to cure deafness which could save the country billions – Yorkshire Live

Thursday, 24 February, 2022

The 'special' Yorkshire firm using stem cell technology to cure deafness which could save the country billions – Yorkshire Live

Microscopic image of the cells within the ear that Rinri Therapeutics work with (Image: Rinri Therapeutics)

 
Founded in 2018 in Yorkshire, Rinri Therapeutics may have a solution to the problem of untreated hearing loss which costs the UK economy a staggering £25.5bn a year.
The firm based at the University of Sheffield is developing the world’s first regenerative cell therapy for sensorineural hearing loss (SNHL), the most common form of deafness for which there is currently no approved pharmacological treatment.
Based on stem cell research, its treatment aims to reverse SNHL by repairing the damaged cellular structure of the inner ear. And according to the company, this technology "has the potential to address huge unmet need globally and help ease the UK’s socio-economic and healthcare burdens".
Read more at: https://www.examinerlive.co.uk/news/local-news/special-yorkshire-firm-using-stem-23134182

Categories :
  • Deafness
  • Latest Headlines
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved